Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript

Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings Conference Call January 22, 2025 8:00 AM ET

Company Participants

Jessica Moore – Vice President, Investor Relations
Joaquin Duato – Chairman and Chief Executive Officer
Joseph Wolk – Executive Vice President, Chief Financial Officer
Jennifer Taubert – Executive Vice President, Worldwide Chairman, Innovative Medicine
John Reed – Executive Vice President, Innovative Medicine, R&D
Tim Schmid – Executive Vice President, Worldwide Chairman, MedTech

Conference Call Participants

Terence Flynn – Morgan Stanley
Joshua Jennings – TD Cowen
Alexandria Hammond – Wolfe Research
Tim Anderson – Bank of America
Lawrence Biegelsen – Wells Fargo
Chris Schott – JPMorgan
David Roman – Goldman Sachs

Operator

Good morning and welcome to Johnson & Johnson’s Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect at this time. [Operator Instructions]

I would now like to turn the conference call over to Johnson & Johnson. You may begin.

Jessica Moore

Hello, everyone. This is Jessica Moore, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company’s review of business results for the fourth quarter and full year 2024 and our financial outlook for 2025.

A few logistics before we get into the details. As a reminder, you can find additional materials, including today’s presentation and associated schedules on the Investor Relations section of the Johnson & Johnson website at investor.jnj.com.

Please note that this presentation contains forward-looking statements regarding, among other things, the company’s future operating and financial performance, market position and business strategy. You are cautioned not to rely on these forward-looking statements, which are based on the current expectations of future events using the information available as of the date of this recording and are subject

#Johnson #Johnson #JNJ #Earnings #Call #Transcript